Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

SELL
$7.46 - $14.14 $93,996 - $178,164
-12,600 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$12.99 - $17.73 $23,382 - $31,914
-1,800 Reduced 12.5%
12,600 $180,000
Q3 2021

Nov 10, 2021

BUY
$14.85 - $21.34 $213,840 - $307,296
14,400 New
14,400 $289,000
Q2 2021

Aug 09, 2021

SELL
$20.19 - $34.17 $262,470 - $444,210
-13,000 Closed
0 $0
Q1 2021

May 05, 2021

BUY
$23.29 - $53.2 $302,770 - $691,600
13,000 New
13,000 $441,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $807M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Avidian Wealth Solutions, LLC Portfolio

Follow Avidian Wealth Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidian Wealth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avidian Wealth Solutions, LLC with notifications on news.